| Literature DB >> 30333027 |
Sarah A Moore1, Nina Hrisos2, Darren Flynn3, Linda Errington4, Christopher Price2, Leah Avery5.
Abstract
BACKGROUND: Increasing physical activity (PA) levels (regular movement such as walking and activities of daily living) and reducing time spent sedentary improves cardiovascular health and reduces morbidity and mortality. Fewer than 30% of independently mobile stroke survivors undertake recommended levels of PA. Sedentary behaviour is also high in this population. We aimed to systematically review the study characteristics and the promise of interventions targeting free-living PA and/or sedentary behaviour in adult stroke survivors.Entities:
Keywords: Behaviour change; Physical activity; Sedentary behaviour; Stroke; Systematic review
Mesh:
Year: 2018 PMID: 30333027 PMCID: PMC6192196 DOI: 10.1186/s12966-018-0730-0
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Fig. 1PRISMA flow-chart
Summary of study characteristics, quality measures and outcomes
| Study | Study characteristics | Quality measures | Intervention (brief description) | Control (brief description) | Primary outcome measure | PA outcome measures | Changes in PA outcome measures |
|---|---|---|---|---|---|---|---|
|
| |||||||
|
|
| 10-week supervised strengthening and conditioning programme | 1-week supervised exercise followed by a 9-week unsupervised home exercise programme | Six-minute walking speed (function) | Human Activity Profile (adjusted activity score) | At 12 months, there was a significant increase in PA in IG compared to CG ( | |
|
| |||||||
|
| 12-week stroke self-management program focusing on increasing self-efficacy | Stroke-related education materials & pamphlets on secondary stroke prevention. 6 bi-weekly telephone calls for 12 wks, during which participants were asked how they were doing that day | Stroke-specific quality of life, assessed using the SSQOL (quality of life) | Frequency of exercise behaviour within the past week measured using validated scale | At 3 and 6 months, PA increased in IG compared to CG (no significant difference) | ||
|
| A theory-based training session delivered after a course of Nordic walking | Control group participants were invited to a single face-to-face training session based on positive gain and a power point presentation on the health benefits of physical activity | Walking-training frequency and duration of each set per week, using questionnaire (PA behaviour) | Walking-training frequency and duration of each set per week, using questionnaire | Stroke patients in IG showed tendency toward increased PA levels compared to those in CG (no significant difference) | ||
|
| Delivery of Physical activity Prescription (PaP) | Usual care | MVPA assessed by Actigraph activity monitor worn on back (PA behaviour) | MVPA and steps per day, assessed by Actigraph activity monitor worn on back | At 6 months, IG showed tendency towards an increase in steps per day compared to CG (no significant difference) | ||
|
| Aerobic training (IG 1) or progressive resistance training (IG 2) | Low-intensity sham training | 6-min walking distance and fast 10-min walking speed (function) | Physical Activity Scale scores expressed as metabolic equivalents | All groups showed significant increases in PA at study end ( | ||
|
| Goal-setting telephone follow-up program | Usual care and educational stroke brochures (IG & CG) | Health behaviour assessed using the Health Promoting Lifestyle Profile II3 (lifestyle behaviour) | 8 item physical activity subscale of the Health Promoting Lifestyle Profile II | PA increased significantly in all groups at 3 and 6 months ( | ||
|
| |||||||
|
| Early aerobic training | Usual care | Physical fitness measured by a graded stress test performed on a cycle ergometer (physical fitness) | Independence in daily and social activities, using the Frenchay Activities Index | No improvements in PA observed in IG or CG | ||
|
| Circuit exercise based rehabilitation | Attention-matched social and educational sessions | Mean number of steps per day measured with StepWatch activity monitor (PA behaviour) | Mean number of steps per day as measured by the StepWatch activity monitor, PADS score | No improvements in PA observed in IG or CG | ||
|
| Educational secondary stroke prevention programme | Usual care and provision of information materials on stroke and stroke prevention | Stroke knowledge; Self health monitoring practice; health behaviours (lifestyle behaviour) | Modified Exercise Scale | No improvements in PA observed in IG or CG | ||
CG, control group; F, female; IG, intervention group; M, male; N, number; PA, physical activity; SD, standard deviation
Fig. 2Risk of Bias in included studies
Intervention details described by TIDieR components
| Study | Item 1 and 2 TIDieR: Brief name and why (including theory) | Item 3–9 TIDieRa: What (materials and procedures), who provided, how, where, when & how much, tailoring | BCTs |
|---|---|---|---|
| Very promising | |||
| Self-monitoring of outcome of behaviour, biofeedback, social support (unspecified), instruction on how to perform the behaviour, demonstration of the behaviour, behavioural practice/rehearsal, graded tasks, adding objects to the environment (n = 8) | |||
|
| |||
| Goal setting (behaviour), problem solving, action planning, review behaviour goal, feedback on behaviour, social support (unspecified), information about health consequences, information about social and environmental consequences, information about emotional consequences, graded tasks, credible source ( | |||
| Goal setting (behaviour), problem solving, action planning, self-monitoring of behaviour, social support (unspecified) ( | |||
| Goal setting (behaviour), action planning, feedback on behaviour, instruction on how to perform the behaviour, behavioural practice/rehearsal, credible source ( | |||
| Biofeedback, instruction on how to perform the behaviour, demonstration of the behaviour, behavioural practice/rehearsal ( | |||
| Goal setting (behaviour), action planning, social support (unspecified), instruction on how to perform the behaviour, information about health consequences, information about social and environmental consequences, credible source ( | |||
| Non-promising | |||
| Action Planning, monitoring of others without feedback, instruction on how to perform the behaviour, demonstration of the behaviour, behavioural practice/rehearsal, graded tasks (n = 6) | |||
| Social support (unspecified), instruction on how to perform the behaviour, demonstration of the behaviour, behavioural practice/rehearsal, graded tasks ( | |||
| Problem solving, self-monitoring of behaviour, social support (unspecified), instruction on how to perform the behaviour, demonstration of the behaviour, behavioural practice/rehearsal, adding objects to the environment (n = 7) | |||
BCT, behaviour change technique; CG, control group; IG, intervention group; min(s), minutes; N, number; PA, physical activity; TIA, transient ischaemic attack; PaP, physical activity prescription;
aItem 10 is not displayed in this table as no studies reported any intervention modifications. Items 11 and 12, which measure intervention fidelity, are not displayed, as fidelity is assessed using the criteria defined by (Bellg et al., 2004 [30])
TIDieR item descriptions in relation to intervention promise
| TIDieR itema | Description | Very Promising | Quite Promising | Non-promising |
|---|---|---|---|---|
|
| Adequately described | 2 | ||
| Not adequately described | 1 | 3 | 3 | |
|
| Borg scale & heart rate monitor | 1 | ||
| Personal log sheets & pedometer | 1 | |||
| Written standardised manual | 1 | |||
| Written information & accelerometer | 1 | |||
| Educational brochures | 1 | |||
| Gym based equipment & heart rate monitor | 1 | 1 | ||
| Not adequately described | 1 | 1 | ||
|
| Structured exercise sessions | 1 | 1 | 2 |
| Group discussions focused on self-efficacy | 1 | |||
| Motivational and volitional strategies | 1 | |||
| Physical activity Prescription | 1 | |||
| Goal-setting telephone follow-up program | 1 | |||
| Educational sessions | 1 | |||
|
| Nurse, assistant physician & social scientist | 1 | ||
| Physiotherapist | 2 | 1 | ||
| Nurse | 1 | 1 | ||
| Not adequately described | 1 | 1 | 1 | |
|
| Face to face exercise sessions | 1 | 1 | 2 |
| Face to face supported self-management | 2 | 1 | ||
| Telephone supported self-management | 2 | |||
|
| Canada | 1 | ||
| USA | 1 | |||
| Germany | 1 | |||
| Sweden | 1 | |||
| Denmark | 1 | |||
| China | 1 | 1 | ||
| Israel | 1 | |||
| New Zealand | 1 | |||
| Outpatient rehabilitation centre/clinic | 1 | 1 | 1 | |
| Inpatient rehabilitation centre | 1 | |||
| Stroke research centre | 1 | |||
| Community based | 1 | 1 | ||
| Not adequately described | 2 | |||
|
| Delivered in single session | 2 | ||
| Delivered over 4 weeks | 1 | |||
| Delivered over 8 weeks | 2 | |||
| Delivered over 10 weeks | 1 | |||
| Delivered over 12 weeks | 3 | |||
| Delivered in acute stages | 1 | |||
| Delivered in chronic stages | 1 | 2 | 1 | |
| Stroke stage not adequately described | 3 | 1 | ||
| 1 contact over intervention delivery period | 2 | |||
| 8 contacts over intervention delivery period | 1 | |||
| 12 contacts over intervention delivery period | 1 | |||
| 24 contacts over intervention delivery period | 2 | |||
| 28 contacts over intervention delivery period | 1 | |||
| 30 contacts over intervention delivery period | 1 | |||
| 36 contacts over intervention delivery period | 1 | |||
|
| Tailored to participants | 1 | 5 | 3 |
| Not tailored to participants | ||||
|
| Modifications reported | |||
| No modifications reported | 1 | 5 | 3 |
aItems 11 & 12 on intervention fidelity are not displayed (assessed using Bellg et al. 2004 [30]
Ratio of BCTs to promise
| BCT | Times used | Presence in very/quite interventions containing | Presence in non-promising interventions | Ratio |
|---|---|---|---|---|
| 1. Action planning | 5 | 4 | 1 | 4.00 |
| 2. Goal setting (behaviour) | 4 | 4 | 0 | 4.00 |
| 3. Credible source | 3 | 3 | 0 | 3.00 |
| 4. Social support (unspecified) | 6 | 4 | 2 | 2.00 |
| 5. Problem solving | 3 | 2 | 1 | 2.00 |
| 6. Biofeedback | 2 | 2 | 0 | 2.00 |
| 7. Feedback on behaviour | 2 | 2 | 0 | 2.00 |
| 8. Information about health consequences | 2 | 2 | 0 | 2.00 |
| 9. Information about social & environmental consequences | 2 | 2 | 0 | 2.00 |
| 10. Instruction on how to perform the behaviour | 7 | 4 | 3 | 1.33 |
| 11. Behavioural practice/rehearsal | 6 | 3 | 3 | 1.00 |
| 12. Graded tasks | 4 | 2 | 2 | 1.00 |
| 13. Adding objects to the environment | 2 | 1 | 1 | 1.00 |
| 14. Self-monitoring of behaviour | 2 | 1 | 1 | 1.00 |
| 15. Demonstration of the behaviour | 5 | 2 | 3 | 0.67 |
| 16. Self-monitoring of outcome of behaviour | 1 | 1 | 0 | 0.00 |
| 17. Monitoring of behaviour by others without feedback | 1 | 0 | 1 | 0.00 |
| 18. Information about emotional consequences | 1 | 1 | 0 | 0.00 |
| 19. Review behaviour goal | 1 | 1 | 0 | 0.00 |
Treatment fidelity scores of included studies
| Very promising | Quite promising | Non-promising | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Olney et al. [31] | Damush et al. [32] | Ludwig et al [33] | Morén et al. [34] | Severinsen et al. [35] | Wan et al. [36] | Katz-Laurer et al [37] | Mudge et al [38] | Sit et al. [39] | Total (%) | ||
| 1) Treatment fidelity strategies for design of study | Ensure same treatment dose within conditions | Y | Y | Y | Y | Y | Y | Y | Y | Y | 9 (100%) |
| Ensure equivalent dose across conditions | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 (89%) | |
| Plan for implementation setbacks | N | N | N | N | N | N | N | N | N | 0 (0%) | |
| 2) Treatment fidelity strategies for monitoring and improving provider training | Standardise training | N | Y | N | Y | N | Y | N | Y | N | 4 (44%) |
| Ensure provider skill acquisition | N | N | N | N | N | Y | N | Y | N | 2 (22%) | |
| Minimise “drift” in provider skills | N | N | N | N | N | N | N | Y | N | 1 (11%) | |
| Accommodate provider differences | N | N | Y | N | N | N | N | Y | N | 2 (22%) | |
| 3) Treatment fidelity strategies for monitoring and improving delivery of treatment | Control for provider differences | N | N | Y | N | N | Y | N | Y | N | 3 (33%) |
| Reduce differences within treatment | N | Y | Y | N | N | Y | N | Y | Y | 5 (56%) | |
| Ensure adherence to treatment protocol | N | Y | Y | N | N | N | Y | Y | Y | 5 (56%) | |
| Minimise contamination between conditions | N | Y | Y | Y | Y | N | Y | Y | Y | 7 (78%) | |
| 4) Treatment fidelity strategies for monitoring and improving receipt of treatment | Ensure participant comprehension | N | N | Y | Y | N | N | N | N | Y | 3 (33%) |
| Ensure participant ability to use cognitive skills | N | N | N | Y | N | N | N | N | Y | 2 (22%) | |
| Ensure participant ability to perform behavioural skills | Y | N | Y | Y | Y | N | Y | Y | Y | 7 (78%) | |
| 5) Treatment fidelity strategies for monitoring and improving enactment of treatment skills | Ensure participant use of cognitive Skills | N | N | N | N | N | N | N | N | Y | 1 (11%) |
| Ensure participant use of behavioural skills | N | N | N | N | Y | N | N | Y | Y | 3 (33%) | |
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
| ||